Developer docs
API playgroundTry for free, no card

Search company profiles

Bruin Biometrics

Full company profile

uuid00031l2

Namestring
Bruin Biometrics
Legal namestring
Bruin Biometrics LLC
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Bruin Biometrics LLC is a privately held, Los Angeles-based medical device company founded in 2007 that pioneered the clinical use of sub-epidermal moisture (SEM) scanning for early pressure injury detection. Its core product, the Provizio SEM Scanner, is an FDA-cleared handheld biocapacitance device (clearances DEN170021 in 2018 and K231830 in 2023) that measures sub-epidermal moisture at the sacrum and heels, detecting developing pressure injuries a median of 5 days before they become visible on the skin. The scanner uses an objective biomarker threshold (SEM Delta ≥0.6) and has been validated across 220+ peer-reviewed publications, 7 independent systematic reviews, and 12 global care guidelines.

The company operates a three-component system: the Provizio hardware, the PIPPA cloud-based digital health platform (HIPAA-compliant, SOC 2 Type 2, HITRUST certified, integrated with 90+ EHR systems via HL7), and the Path to Zero implementation advisory program. In late 2025 it added an AI-enabled Protocol Intelligent Assistant (PIA) that compresses protocol development from weeks to minutes and a fixed-sensor scanner variant that eliminates single-use components. Revenue is generated through a hybrid model combining scanner hardware sales, PIPPA SaaS subscriptions, professional services under Path to Zero, and a Reimbursement Support Program leveraging CMS ICD-10-PCS code XX2KXP9.

Bruin Biometrics sells via direct enterprise field sales and clinical champion models to U.S. hospitals and health systems (academic medical centers, VA, ICU, oncology, surgical and transplant units) and internationally, including UK hospices. Reported customer outcomes include 93% reduction in preventable HAPIs, 7.5x prevention ROI, and $3.4M net annual savings for an average 250-bed hospital. The company has disclosed ~$20.4M in funding across 2014–2018, has 11–50 employees, and operates with no parent company or subsidiaries.

Short descriptiontext

Bruin Biometrics makes the FDA-cleared Provizio SEM Scanner and PIPPA digital platform that detect pressure injuries 5 days before visible signs, selling to U.S. and international hospitals, academic medical centers, ICUs, oncology units, and the Veterans Administration through enterprise direct sales and a hybrid hardware-plus-SaaS-plus-services model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pressure injury detection, medical device manufacturing, wound care solutions, sub-epidermal moisture scanning, hospital acquired conditions
Industry2 codes
PRIMARYHLAHACAA
Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Pressure Injury Prevention Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Provizio SEM Scanner Hardware
TypeHardware Sales
Description

Sale of FDA-cleared SEM scanning hardware device to hospitals and healthcare facilities. One-time capital purchase with ongoing sensor costs.

bruinbiometrics.com
2PIPPA Digital Platform Subscription
TypeSubscription Recurring
Description

Cloud-based SaaS platform subscription for SEM data management, analytics, reporting, and EHR integration. Provides real-time PI intelligence across patient, unit, and facility levels.

bruinbiometrics.com
3Path to Zero Implementation Services
TypeProfessional Services
Description

Expert advisory services, workflow design, clinical implementation, training, and ongoing support. Evidence-based PI prevention optimization program delivered alongside technology deployment.

bruinbiometrics.com
4Reimbursement Support Program
TypeManaged Services
Description

Program to help hospitals obtain CMS reimbursement for pressure injuries identified as Present on Admission (POA) using the Provizio SEM Scanner with ICD-10-PCS procedure code XX2KXP9.

prnewswire.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Supply Chain
Pricing details2 tiers
1Enterprise healthcare systems
ModelHybridBilling cadenceAnnual
Notes

Quote-based pricing combining hardware purchase, software subscription, and implementation services. Customized ROI analysis based on facility size, bed count, and current PI incidence rates.

bruinbiometrics.com
2ROI-based value pricing
ModelOutcome Based/ PerformanceBilling cadenceAnnual
Notes

Every $1 invested returns $7.45 in avoided treatment costs and reduced length of stay. Average 7.5x prevention ROI. Break-even achieved within same budget year.

bruinbiometrics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Provizio SEM Scanner
Description

FDA-cleared handheld SEM scanning device that detects pressure injuries 5 days (median) before visual skin assessments using biocapacitance technology to measure sub-epidermal moisture.

bruinbiometrics.com
+2 more records
Core offering1 text field

Bruin Biometrics designs, manufactures, and sells the FDA-cleared Provizio SEM Scanner, a handheld biocapacitance device that measures Sub-Epidermal Moisture (SEM) to detect developing pressure injuries approximately 5 days (median) before visible skin signs appear. The hardware is sold to hospitals and health systems, paired with the PIPPA cloud-based digital platform for data capture, EHR integration, and reporting, plus the Path to Zero advisory program for clinical implementation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 93% reduction in preventable HAPIs (systematic review of 17 studies)
+7 more records
Product overview1 text field

Bruin Biometrics offers a three-component pressure injury prevention system centered on the Provizio SEM Scanner — the only FDA-cleared device using biocapacitance to detect sub-epidermal moisture (SEM) as an early biomarker of tissue damage, identifying injuries 5 days (median) before visible signs appear. The PIPPA Digital Platform aggregates SEM scan data for real-time insights, EHR integration, and compliance reporting across 90+ systems. The Path to Zero Program provides expert implementation advisory services guiding healthcare organizations through a structured six-step methodology to adopt SEM technology and achieve zero HAPI outcomes. The Protocol Intelligent Assistant (PIA) is an AI-powered module that generates customized prevention protocols from SEM data in minutes rather than weeks. A new fixed-sensor scanner variant eliminates single-use components for sustainability.

Product and service5 records
1Provizio SEM Scanner
CategoryPressure injury prevention medical device
Description

FDA-cleared handheld biocapacitance medical device that measures Sub-Epidermal Moisture (SEM) as an objective biomarker of developing pressure injuries, detecting tissue damage approximately 5 days (median) before visual skin assessment. Designed for use at the sacrum and heels in hospitals and healthcare facilities.

2PIPPA Digital Platform
CategoryDigital health SaaS platform
Description

HIPAA-compliant, HITRUST and SOC 2 Type 2 certified cloud-based digital health platform that aggregates real-time SEM scan data, provides patient/unit/facility-level insights, automates reporting, and integrates with 90+ EHR systems via HL7/FHIR for pressure injury prevention and compliance documentation.

3Path to Zero Program
CategoryImplementation and advisory services
Description

Evidence-based implementation and clinical advisory program that guides healthcare organizations through a six-step methodology (Assess, Design, Educate, Implement, Measure, Share) to adopt SEM scanning technology, optimize prevention workflows, and achieve sustained zero HAPI outcomes.

4Protocol Intelligent Assistant (PIA)
CategoryAI-enabled clinical decision support
Description

AI-enabled assistant that analyzes SEM data and clinical context to generate customized pressure injury prevention protocols, reducing protocol development time from 5–6 weeks to 5–6 minutes.

5Fixed-Sensor Provizio SEM Scanner
CategoryPressure injury prevention medical device
Description

New scanner variant that eliminates single-use sensor components to reduce medical waste and costs while maintaining FDA clearance and SEM scanning performance.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1NPIAP (National Pressure Injury Advisory Panel)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-01
Description

PIPPA platform integrates NPIAP's Standardized Pressure Injury Prevention Protocol (SPIPP) Checklist 2.0, embedding clinical best practices into the digital workflow for standardized PI prevention protocols.

bruinbiometrics.com
Strategic tierCoreTypeTechnology or Integration
Description

PIPPA platform integrates with Epic EHR systems for automated SEM Delta data capture, intervention documentation, and eCQM reporting. SEM scan data flows seamlessly into Epic workflows, eliminating manual data entry and supporting POA documentation.

Strategic tierCoreTypeTechnology or Integration
Description

HL7 FHIR standards support for EHR integration across 90+ systems, enabling interoperability and automated data exchange for SEM scan results.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Arjo provides patient handling and pressure-injury prevention surfaces (e.g., Auralis, AtmosAir) used widely in hospitals and long-term care. It overlaps with Bruin Biometrics on the pressure-injury prevention workflow but competes via reactive support surfaces rather than early objective detection.

TypeBroad incumbent
Description

Stryker acquired Sage Products, a maker of pressure-injury prevention skin care and preps, and offers a broad acute-care portfolio. It competes with Bruin Biometrics in pressure-injury prevention but again via products and surfaces, not biocapacitance-based SEM scanning.

TypeBroad incumbent
Description

ConvaTec's Advanced Wound Care division supplies dressings, negative-pressure wound therapy, and skin-care products used in pressure-injury prevention and treatment. It is a comparable enterprise sales motion targeting the same hospital decision-makers.

TypeBroad incumbent
Description

3M's Health Care business (spun off as Solventum, including KCI V.A.C. therapy) is a major wound-care and hospital products incumbent. It overlaps with Bruin Biometrics in hospital pressure-injury workflows but addresses them through dressings and NPWT rather than early detection.

TypeBroad incumbent
Description

Smith+Nephew is a major advanced wound management player (ALLEVYN, PICO negative-pressure wound therapy). It competes with Bruin Biometrics in pressure-injury treatment economics rather than early detection, but targets the same hospital budgets and quality leaders.

TypeEmerging player
Description

Tissue Analytics, now part of Net Health, offers AI-powered digital wound imaging, measurement, and EHR-integrated documentation. It competes with PIPPA in the digital pressure-injury workflow and EHR-integration layer for wound care.

TypeBroad incumbent
Description

Hill-Rom (acquired by Baxter) is a dominant supplier of hospital beds and pressure-injury prevention surfaces such as the ICON and Centrella lines. It competes with Bruin Biometrics in pressure-injury prevention broadly but lacks an FDA-cleared objective tissue-damage detection device like the Provizio SEM Scanner.

TypeDirect peer
Description

Mölnlycke is a leading global wound-care and pressure-injury prevention company (Mepilex Border, Mepitel, etc.). It addresses pressure-injury management through dressings and prevention protocols and is a natural comparison point for Bruin Biometrics' clinical workflow in hospitals.

TypeBroad incumbent
Description

Coloplast's Wound Care division provides dressings and skin-care products for pressure-injury prevention and treatment. It competes for the same hospital wound-care budget allocation as Bruin Biometrics, though with a focus on treatment rather than early biomarker detection.

TypeEmerging player
Description

MolecuLight makes handheld point-of-care fluorescence imaging devices for real-time wound bacterial burden assessment. It is an emerging digital wound-assessment player with a similar bedside-handheld, objective-detection value proposition to Provizio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bruin Biometrics

Pressure Injury Prevention Medical Devicesbruinbiometrics.com

Bruin Biometrics makes the FDA-cleared Provizio SEM Scanner and PIPPA digital platform that detect pressure injuries 5 days before visible signs, selling to U.S. and international hospitals, academic medical centers, ICUs, oncology units, and the Veterans Administration through enterprise direct sales and a hybrid hardware-plus-SaaS-plus-services model.

What Bruin Biometrics does

Bruin Biometrics LLC is a privately held, Los Angeles-based medical device company founded in 2007 that pioneered the clinical use of sub-epidermal moisture (SEM) scanning for early pressure injury detection. Its core product, the Provizio SEM Scanner, is an FDA-cleared handheld biocapacitance device (clearances DEN170021 in 2018 and K231830 in 2023) that measures sub-epidermal moisture at the sacrum and heels, detecting developing pressure injuries a median of 5 days before they become visible on the skin. The scanner uses an objective biomarker threshold (SEM Delta ≥0.6) and has been validated across 220+ peer-reviewed publications, 7 independent systematic reviews, and 12 global care guidelines.

The company operates a three-component system: the Provizio hardware, the PIPPA cloud-based digital health platform (HIPAA-compliant, SOC 2 Type 2, HITRUST certified, integrated with 90+ EHR systems via HL7), and the Path to Zero implementation advisory program. In late 2025 it added an AI-enabled Protocol Intelligent Assistant (PIA) that compresses protocol development from weeks to minutes and a fixed-sensor scanner variant that eliminates single-use components. Revenue is generated through a hybrid model combining scanner hardware sales, PIPPA SaaS subscriptions, professional services under Path to Zero, and a Reimbursement Support Program leveraging CMS ICD-10-PCS code XX2KXP9.

Bruin Biometrics sells via direct enterprise field sales and clinical champion models to U.S. hospitals and health systems (academic medical centers, VA, ICU, oncology, surgical and transplant units) and internationally, including UK hospices. Reported customer outcomes include 93% reduction in preventable HAPIs, 7.5x prevention ROI, and $3.4M net annual savings for an average 250-bed hospital. The company has disclosed ~$20.4M in funding across 2014–2018, has 11–50 employees, and operates with no parent company or subsidiaries.

Bruin Biometrics firmographics

Firmographics
Name
Bruin Biometrics
Legal name
Bruin Biometrics LLC
Website
https://bruinbiometrics.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
Bruin Biometrics makes the FDA-cleared Provizio SEM Scanner and PIPPA digital platform that detect pressure injuries 5 days before visible signs, selling to U.S. and international hospitals, academic medical centers, ICUs, oncology units, and the Veterans Administration through enterprise direct sales and a hybrid hardware-plus-SaaS-plus-services model.
Ownership category
akta.pro rank

Bruin Biometrics industry classification

Industry
Product category
Pressure Injury Prevention Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHACAA
Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Pressure injury detection
  • Medical device manufacturing
  • Wound care solutions
  • Sub-epidermal moisture scanning
  • Hospital acquired conditions

Where Bruin Biometrics is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Bruin Biometrics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Supply Chain

Revenue model

  1. Provizio SEM Scanner Hardware: Sale of FDA-cleared SEM scanning hardware device to hospitals and healthcare facilities. One-time capital purchase with ongoing sensor costs.
  2. PIPPA Digital Platform Subscription: Cloud-based SaaS platform subscription for SEM data management, analytics, reporting, and EHR integration. Provides real-time PI intelligence across patient, unit, and facility levels.
  3. Path to Zero Implementation Services: Expert advisory services, workflow design, clinical implementation, training, and ongoing support. Evidence-based PI prevention optimization program delivered alongside technology deployment.
  4. Reimbursement Support Program: Program to help hospitals obtain CMS reimbursement for pressure injuries identified as Present on Admission (POA) using the Provizio SEM Scanner with ICD-10-PCS procedure code XX2KXP9.

Pricing tiers

ModelBillingPrice
HybridAnnualEnterprise healthcare systems
Outcome Based/ PerformanceAnnualROI-based value pricing

Go-to-market motion3 records

Distribution channels2 records

Marketing channels10 records

Bruin Biometrics product offering

Product offering

Core offering

Bruin Biometrics designs, manufactures, and sells the FDA-cleared Provizio SEM Scanner, a handheld biocapacitance device that measures Sub-Epidermal Moisture (SEM) to detect developing pressure injuries approximately 5 days (median) before visible skin signs appear. The hardware is sold to hospitals and health systems, paired with the PIPPA cloud-based digital platform for data capture, EHR integration, and reporting, plus the Path to Zero advisory program for clinical implementation.

Product overview

Bruin Biometrics offers a three-component pressure injury prevention system centered on the Provizio SEM Scanner — the only FDA-cleared device using biocapacitance to detect sub-epidermal moisture (SEM) as an early biomarker of tissue damage, identifying injuries 5 days (median) before visible signs appear. The PIPPA Digital Platform aggregates SEM scan data for real-time insights, EHR integration, and compliance reporting across 90+ systems. The Path to Zero Program provides expert implementation advisory services guiding healthcare organizations through a structured six-step methodology to adopt SEM technology and achieve zero HAPI outcomes. The Protocol Intelligent Assistant (PIA) is an AI-powered module that generates customized prevention protocols from SEM data in minutes rather than weeks. A new fixed-sensor scanner variant eliminates single-use components for sustainability.

Differentiator

Problem solved

Functional benefit

Brands

  • Provizio SEM Scanner: FDA-cleared handheld SEM scanning device that detects pressure injuries 5 days (median) before visual skin assessments using biocapacitance technology to measure sub-epidermal moisture.
  • PIPPA Digital Platform
  • Path to Zero Program

Products and services

  • Provizio SEM Scanner FDA-cleared handheld biocapacitance medical device that measures Sub-Epidermal Moisture (SEM) as an objective biomarker of developing pressure injuries, detecting tissue damage approximately 5 days (median) before visual skin assessment. Designed for use at the sacrum and heels in hospitals and healthcare facilities.
  • PIPPA Digital Platform HIPAA-compliant, HITRUST and SOC 2 Type 2 certified cloud-based digital health platform that aggregates real-time SEM scan data, provides patient/unit/facility-level insights, automates reporting, and integrates with 90+ EHR systems via HL7/FHIR for pressure injury prevention and compliance documentation.
  • Path to Zero Program Evidence-based implementation and clinical advisory program that guides healthcare organizations through a six-step methodology (Assess, Design, Educate, Implement, Measure, Share) to adopt SEM scanning technology, optimize prevention workflows, and achieve sustained zero HAPI outcomes.
  • Protocol Intelligent Assistant (PIA) AI-enabled assistant that analyzes SEM data and clinical context to generate customized pressure injury prevention protocols, reducing protocol development time from 5–6 weeks to 5–6 minutes.
  • Fixed-Sensor Provizio SEM Scanner New scanner variant that eliminates single-use sensor components to reduce medical waste and costs while maintaining FDA clearance and SEM scanning performance.

Quantifiable outcome

  • 93% reduction in preventable HAPIs (systematic review of 17 studies)
  • +7 more outcomes

Companies that use Bruin Biometrics

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Bruin Biometrics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature6 records

Bruin Biometrics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • NPIAP (National Pressure Injury Advisory Panel)coreStrategic or Co-development Partner · 1 November 2025PIPPA platform integrates NPIAP's Standardized Pressure Injury Prevention Protocol (SPIPP) Checklist 2.0, embedding clinical best practices into the digital workflow for standardized PI prevention protocols.
  • Epic Systems CorporationcoreTechnology or IntegrationPIPPA platform integrates with Epic EHR systems for automated SEM Delta data capture, intervention documentation, and eCQM reporting. SEM scan data flows seamlessly into Epic workflows, eliminating manual data entry and supporting POA documentation.
  • HL7 InternationalcoreTechnology or IntegrationHL7 FHIR standards support for EHR integration across 90+ systems, enabling interoperability and automated data exchange for SEM scan results.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Bruin Biometrics competitors and assessment

Company assessment

Broad incumbents

  • Arjo: Arjo provides patient handling and pressure-injury prevention surfaces (e.g., Auralis, AtmosAir) used widely in hospitals and long-term care. It overlaps with Bruin Biometrics on the pressure-injury prevention workflow but competes via reactive support surfaces rather than early objective detection.
  • Stryker (Sage Products): Stryker acquired Sage Products, a maker of pressure-injury prevention skin care and preps, and offers a broad acute-care portfolio. It competes with Bruin Biometrics in pressure-injury prevention but again via products and surfaces, not biocapacitance-based SEM scanning.
  • ConvaTec: ConvaTec's Advanced Wound Care division supplies dressings, negative-pressure wound therapy, and skin-care products used in pressure-injury prevention and treatment. It is a comparable enterprise sales motion targeting the same hospital decision-makers.
  • 3M Health Care (Solventum / KCI): 3M's Health Care business (spun off as Solventum, including KCI V.A.C. therapy) is a major wound-care and hospital products incumbent. It overlaps with Bruin Biometrics in hospital pressure-injury workflows but addresses them through dressings and NPWT rather than early detection.
  • Smith+Nephew: Smith+Nephew is a major advanced wound management player (ALLEVYN, PICO negative-pressure wound therapy). It competes with Bruin Biometrics in pressure-injury treatment economics rather than early detection, but targets the same hospital budgets and quality leaders.
  • Hill-Rom (now part of Baxter): Hill-Rom (acquired by Baxter) is a dominant supplier of hospital beds and pressure-injury prevention surfaces such as the ICON and Centrella lines. It competes with Bruin Biometrics in pressure-injury prevention broadly but lacks an FDA-cleared objective tissue-damage detection device like the Provizio SEM Scanner.
  • Coloplast: Coloplast's Wound Care division provides dressings and skin-care products for pressure-injury prevention and treatment. It competes for the same hospital wound-care budget allocation as Bruin Biometrics, though with a focus on treatment rather than early biomarker detection.

Emerging players

  • Tissue Analytics (a Net Health company): Tissue Analytics, now part of Net Health, offers AI-powered digital wound imaging, measurement, and EHR-integrated documentation. It competes with PIPPA in the digital pressure-injury workflow and EHR-integration layer for wound care.
  • MolecuLight: MolecuLight makes handheld point-of-care fluorescence imaging devices for real-time wound bacterial burden assessment. It is an emerging digital wound-assessment player with a similar bedside-handheld, objective-detection value proposition to Provizio.

Direct peers

  • Mölnlycke Health Care: Mölnlycke is a leading global wound-care and pressure-injury prevention company (Mepilex Border, Mepitel, etc.). It addresses pressure-injury management through dressings and prevention protocols and is a natural comparison point for Bruin Biometrics' clinical workflow in hospitals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Bruin Biometrics social profiles

Digital presence

Bruin Biometrics compliance and trust

Trust signal

Compliance5 records

Bruin Biometrics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bruin Biometrics leadership team

Management profile

Number of profiles

Profiles7 records

Bruin Biometrics funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bruin Biometrics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bruin Biometrics

What does Bruin Biometrics do?

Bruin Biometrics designs, manufactures, and sells the FDA-cleared Provizio SEM Scanner, a handheld biocapacitance device that measures Sub-Epidermal Moisture (SEM) to detect developing pressure injuries approximately 5 days (median) before visible skin signs appear. The hardware is sold to hospitals and health systems, paired with the PIPPA cloud-based digital platform for data capture, EHR integration, and reporting, plus the Path to Zero advisory program for clinical implementation.

Is Bruin Biometrics a public or private company?

Bruin Biometrics is a private company. It is classified as unknown and is currently operating.

When was Bruin Biometrics founded?

Bruin Biometrics was founded in 2007. It employs 11 to 50 people.

Where is Bruin Biometrics based?

Bruin Biometrics is headquartered in Los Angeles, United States, in the North America region.

How does Bruin Biometrics make money?

Four revenue lines are on record. Provizio SEM Scanner Hardware is the primary driver. The others are PIPPA Digital Platform Subscription, path to Zero Implementation Services and reimbursement Support Program.

Who are Bruin Biometrics's main competitors?

Broad incumbents on record are Arjo, Stryker (Sage Products), ConvaTec, 3M Health Care (Solventum / KCI), Smith+Nephew, Hill-Rom (now part of Baxter) and Coloplast. Emerging players are Tissue Analytics (a Net Health company) and MolecuLight. Mölnlycke Health Care is listed as a direct peer.

Does Bruin Biometrics have an API?

No public API is recorded for Bruin Biometrics.

What industry is Bruin Biometrics in?

Bruin Biometrics's product category is Pressure Injury Prevention Medical Devices. Its primary akta.pro industry code is HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireSEM Scanning Crosses the Global Guideline Threshold: Elevated to Recommended Pressure Injury Prevention TechnologyThe Fourth Edition of the International Clinical Practice Guideline for pressure injury prevention has issued a positive, conditional recommendation for using sub-epidermal moisture (SEM) scanning technology to detect early tissue damage. Bruin Biometrics' Provizio® scanner is highlighted as a key tool enabling this shift from visual assessment to objective biomarker measurement, which clinical evidence suggests can reduce pressure injuries by 64%. This update marks a significant change from the 2019 guideline, aiming to improve patient safety and reduce healthcare costs through earlier intervention.TrendHunter.comTech-Enhanced Medical Solutions : Bruin BiometricsBruin Biometrics introduced an AI tool to accelerate patient care protocol creation from weeks to minutes, integrating with its Provizio SEM Scanner and digital PIPPA platform. The company also redesigned a reusable scanner component to reduce medical waste and costs, and secured third-party certifications for data security and privacy.MorningstarBruin Biometrics Accelerates Pressure Injury Prevention with Artificial Intelligence and Sustainable InnovationBruin Biometrics announced a series of advancements including an AI-enabled protocol intelligent assistant (PIA), a new fixed-sensor variant of its Provizio SEM Scanner, and HITRUST/SOC 2 certifications for its PIPPA digital health platform. The PIA tool reduces pressure injury protocol development time from 5–6 weeks to 5–6 minutes and is built on the company's SEM technology, which has demonstrated a 92% reduction in pressure injury incidence, while the new scanner design eliminates single-use sensor components to reduce medical waste and costs. The certifications extend AES-256 encryption and FIPS 140-2 data protection standards across the company's digital ecosystem.PR NewswireBruin Biometrics Accelerates Pressure Injury Prevention with Artificial Intelligence and Sustainable InnovationBruin Biometrics unveiled an AI protocol assistant that cuts pressure injury prevention protocol development from weeks to minutes, and announced a fixed-sensor Provizio SEM scanner to reduce waste. The company also confirmed its PIPPA platform earned HITRUST and SOC 2 certifications. The tools aim to improve prevention outcomes and sustainability.PR NewswireBruin Biometrics Announces Program to Help Providers Access Reimbursement for Pressure Injuries Detected on AdmissionBruin Biometrics announced a new program to help hospitals obtain reimbursement for pressure injuries identified as Present on Admission (POA) using their Provizio SEM Scanner. In 2024, CMS assigned the scanner a specific ICD-10-PCS procedure code (XX2KXP9) recognizing its use in measuring sub-epidermal moisture for pressure injury assessment, enabling providers to bill for care previously classified as non-reimbursable hospital-acquired conditions. The company CEO stated that hospitals not scanning may be forgoing millions of dollars in annual reimbursement for pressure injury prevention and management care.YahooBruin Biometrics Announces PIPPA, The Only Medical Pressure Injury Technology To Integrate NPIAP's SPIPP Checklist 2.0Bruin Biometrics announced that its PIPPA platform now integrates NPIAP's SPIPP checklist 2.0, the only medical pressure injury technology to do so. The integration automates checklist production and supports real-time data reporting, aiming to reduce hospital-acquired pressure injuries. PIPPA also integrates with the Provizio SEM Scanner for early risk detection.PR NewswireProvizio® SEM Scanner Achieves Expanded FDA Claims and CMS Procedure Code in the United States Further Advancing Pressure Injury Prevention for Patients and ProvidersBruin Biometrics LLC has received expanded FDA labeling recognition for its Provizio SEM Scanner, with the agency acknowledging that sub-epidermal moisture (SEM) is equivalent to persistent focal edema and that the device measures and monitors SEM for pressure injury prevention. The US Centers for Medicare and Medicaid Services (CMS) has approved a new ICD-10 PCS procedure code (XX2KXP9) for the SEM scanning procedure, effective April 1, 2024, enabling standardized coding and documentation of the procedure. These regulatory milestones are expected to help healthcare providers identify and document pressure damage on admission, particularly benefiting dark-skin-toned patients, and will play a significant role in reducing Medicare penalties associated with missed hospital-acquired pressure injury diagnoses.PR NewswirePressure Injury Prevention Sensor Provided Free at the Point of Care to all Community Patients in the U.K. Under New Drug Tariff ListingsBruin Biometrics has secured Drug Tariff listings in the U.K., making its Provizio® SEM Scanner Sensor free at the point of care for over one million community patients across England, Wales, Scotland, and Northern Ireland. This unprecedented listing by the NHS Business Services Authority allows clinicians to prevent pressure injuries centrally funded, aiming to reduce the significant costs associated with wound management within the National Health Service.PR NewswireBruin Biometrics, LLC (BBI), and Arjo (ARJO-B.ST) agree equity investment and exclusive worldwide distribution rights for pressure ulcer SEM ScannerArjo agreed to acquire an equity stake in Bruin Biometrics and become its exclusive worldwide distributor for the Provizio SEM Scanner, a pressure ulcer assessment device. The deal aims to strengthen Arjo's wound care offering and drive prevention of pressure injuries, with the distribution agreement signed on October 8, 2020.Deloitte United StatesMedTech and the IoMT are crucial drivers of value-based careThe article presents a 2025 outlook for the MedTech industry, predicting that companies will increasingly adopt Value-Based Health Care (VBHC) arrangements and integrate IoMT technologies to enhance patient outcomes and secure market share. It highlights specific historical precedents such as Pear Therapeutics' FDA approvals for digital therapeutics and risk-sharing models developed by Medtronic and Bruin Biometrics. Additionally, it notes how the pandemic accelerated the adoption of remote monitoring tools, citing Philips' EUA for its IntelliVue Patient Monitors.